193 related articles for article (PubMed ID: 17112628)
21. [The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis].
Merle P; Zoulim F; Vitvitski L; Trépo C
Gastroenterol Clin Biol; 2000 Dec; 24(12):1166-76. PubMed ID: 11173729
[No Abstract] [Full Text] [Related]
22. Chronic hepatitis B virus infection.
McMahon BJ
Med Clin North Am; 2014 Jan; 98(1):39-54. PubMed ID: 24266913
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of chronic hepatitis B].
Morović M
Acta Med Croatica; 2005; 59(5):429-32. PubMed ID: 16381239
[TBL] [Abstract][Full Text] [Related]
24. Histological and nonhistological criteria in the evaluation of liver involvement in chronic hepatitis C.
Mateescu RB; Rimbaş M; Stăniceanu F; Zurac S; Dragomir P; Voiosu MR; Tătaru M; Zota M; Bucurică S
Rom J Intern Med; 2006; 44(2):117-30. PubMed ID: 17236293
[TBL] [Abstract][Full Text] [Related]
25. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
Yoshida H; Omata M
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
[No Abstract] [Full Text] [Related]
26. Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma.
Chong CC; Lai PB
Br J Surg; 2013 May; 100(6):724-5. PubMed ID: 23475744
[No Abstract] [Full Text] [Related]
27. Host factors may influence response to antiviral therapy in chronic hepatitis B virus infections.
Schildgen O
Med Hypotheses; 2011 Mar; 76(3):417-20. PubMed ID: 21115226
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B.
Wong GL; Yiu KK; Wong VW; Tsoi KK; Chan HL
Aliment Pharmacol Ther; 2010 Nov; 32(9):1059-68. PubMed ID: 20807216
[TBL] [Abstract][Full Text] [Related]
29. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
30. Antiviral therapy for chronic hepatitis B: are we doing any good to patients?
Wong VW; Sung JJ
J Antimicrob Chemother; 2009 Aug; 64(2):223-6. PubMed ID: 19468026
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis B and hepatitis C, a high stake for public health: how to reconcile health cost control and public health expenses?].
Allerg Immunol (Paris); 1997 Sep; 29(7):215-8. PubMed ID: 9432191
[No Abstract] [Full Text] [Related]
32. Immune responses in hepatitis B virus infection.
Rehermann B
Semin Liver Dis; 2003 Feb; 23(1):21-38. PubMed ID: 12616448
[TBL] [Abstract][Full Text] [Related]
33. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?].
Harada H; Iga D; Arisaka Y; Mitsuhashi Y; Kamitsukasa H; Yagura M; Endou H; Kawashima H
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870
[No Abstract] [Full Text] [Related]
34. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
35. When (and When Not) to Treat Patients With HBV Infection.
Fricker ZP; Reddy KR
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2644-2647. PubMed ID: 31154025
[No Abstract] [Full Text] [Related]
36. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
Mazzella G; Villanova N; Amed MA; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
J Chemother; 1989 Jul; 1(4 Suppl):1094-5. PubMed ID: 16312786
[No Abstract] [Full Text] [Related]
37. Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?
Chien RN
J Gastroenterol Hepatol; 2011 Dec; 26(12):1699-701. PubMed ID: 22097937
[No Abstract] [Full Text] [Related]
38. Chemoprevention of hepatocellular carcinoma in chronic hepatitis B with lamivudine?
Lim LY; Kowdley KV
Gastroenterology; 2005 Dec; 129(6):2120-2; discussion 2122. PubMed ID: 16344085
[No Abstract] [Full Text] [Related]
39. Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.
Zeisel MB; Lucifora J; Mason WS; Sureau C; Beck J; Levrero M; Kann M; Knolle PA; Benkirane M; Durantel D; Michel ML; Autran B; Cosset FL; Strick-Marchand H; Trépo C; Kao JH; Carrat F; Lacombe K; Schinazi RF; Barré-Sinoussi F; Delfraissy JF; Zoulim F
Gut; 2015 Aug; 64(8):1314-26. PubMed ID: 25670809
[TBL] [Abstract][Full Text] [Related]
40. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
Ueno Y; Sollano JD; Farrell GC
J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
